China News Service, Jiaxing, June 19 (Zhou Sunyu) On the 19th, the Yangtze River Delta Medical Device High-Quality Development Summit Forum was held in Jiashan County, Jiaxing City, Zhejiang Province.

According to statistics, as of 2020, the size of China's medical device market is approximately 734.1 billion yuan (RMB, the same below), an increase of 18.3% year-on-year, almost 4 times the global medical device growth rate.

Regardless of scale or quality, the development of China's medical device field has entered a new stage of high-quality development.

How to better achieve this goal?

At the forum that day, practitioners started discussions with the key word "conversion of ideas".

One of the changes: understanding internationalization

  Meng Dongping, secretary of the Party Committee of the China Chamber of Commerce for Import and Export of Medicines and Health Products, said that China’s current medical and health industry, especially the medical device industry, is already at the center of the world stage. While achieving results, there are also many core technologies that are "stuck-necked", which are valuable in the global supply chain. The chain has been at the lowest end for a long time.

  “Many of our companies do not understand the trade rules, customer needs, and consumer preferences of exporting countries.” Meng Dongping said, “Some companies believe that simply participating in a few international conferences and introducing a few international projects is internationalization. It's one-sided."

  Meng Dongping believes that it is the above-mentioned reasons that many companies are only satisfied with the trade side and are unwilling to invest resources in R&D and innovation, resulting in companies not having core competitiveness and initiative in the international arena.

  In her view, the establishment of an international cognition system, R&D ideas, quality control channels and overall business layout are the key to winning international competition.

From a higher perspective, life and health matter to all mankind, and practitioners in the medical industry should establish a sense of guardianship and awe of life.

  "We must use the best products and services to protect the people and benefit the world." Meng Dongping said, "The medical industry in the three provinces and one city of the Yangtze River Delta ranks among the top in the country, and local practitioners have more responsibility and obligation to play a good role. Character."

Photo by Zhou Sunyu at the forum site

Transformation 2: Patent Transformation and Intellectual Property

  "In the field of biomedicine, our patent conversion rate is about 10%, and 40% in developed countries." Zhu Tongyu, deputy director of the Development Center of Shanghai Shenkang Hospital and deputy dean of Shanghai Medical College of Fudan University, appealed, "Patent results will not be transformed. It’s better to do basic research."

  Zhu Tongyu bluntly said that many researchers now fall into the "heroes theory of the number of papers" and fail to translate scientific research results into practical applications, which has caused a waste of resources.

He believes that a hospital is like a medical center, and a corresponding intellectual property transformation system should be established to allow clinical and scientific research to form a benign interaction to achieve sustainable development.

  The emphasis on intellectual property rights also applies to enterprises. Song Xiaoting, secretary of the Party Committee of the Shanghai International Intellectual Property Institute of Tongji University, believes that the current competition among enterprises is no longer a competition of price and employment costs, but a competition of technological content. The protection of property rights has become the key to achieving high-quality development of the medical device industry.

  "Enterprises must analyze and judge the intellectual property rights of each stage of the entire life cycle of a medical device, so as to maintain a competitive advantage in the market." Song Xiaoting said that from data to software to hardware, attention should be paid.

Change Three: Innovation and Investment

  "At present, China has entered the'innovation stage'. Without innovation, there will be no further development." Tan Weihong, an academician of the Chinese Academy of Sciences, said that the pharmaceutical industry has the characteristics of long research and development cycles and large capital needs. Many companies that started with generic drugs in the past have now accumulated With sufficient capital, it is now time to change the concept towards innovative R&D development.

  According to Xu Xuemin, member of the Standing Committee of the Party Committee and Vice President of Shanghai Jiaotong University, scientific researchers do a good job of "0 to 1" is an important part of achieving high-quality development. "Difficult diseases are a problem for the whole world. We may not To'follow the steps of others', we can surpass and even lead future development through innovations in the '0 to 1'stage."

  Xu Xuemin said that the realization of this goal is inseparable from financial support.

However, in the current medical investment, capital still tends to "make quick money", and there is a phenomenon of "follow the trend and imitate".

  "Some investors do not have the professional ability to identify innovative projects. Before investing, they often check whether there are similar projects abroad. If there are, then invest." She suggested that investors should have "patience and confidence" and strengthen their professional knowledge. Discover potential quality projects.

  Fu Xiao, head of the Yangtze River Delta City Economic Coordination Office and the Social Development Group of the Yangtze River Delta Regional Cooperation Office, also holds a similar view. He believes that to achieve high-quality development of the industry, changing investment concepts is the key.

  "In the past, we paid attention to the'short-term effect' in attracting investment, but in the current era of innovation, without a long-term perspective, the effect is difficult to achieve." Fu Xiao said.

  Participants believe that the three provinces and one city in the Yangtze River Delta region have their own advantages in the medical field after years of development. Under the current background of the integrated development of the Yangtze River Delta, the positive interaction between resources should be strengthened.

On the same day, the Yangtze River Delta Regional Cooperation Office, China Medical Insurance Chamber of Commerce Medical Device International Cooperation Branch, Yangtze River Delta City Economic Coordination Association Smart Medical Development Alliance, Shanghai, Jiangsu, Zhejiang and Anhui Medical Device Industry Associations and other industry practitioners jointly launched the "Yangtze River Delta Proposal for the Alliance for the High-quality Collaborative Development of Medical Devices.

  It is reported that the proposal aims to collaborate with government departments, industry organizations, scientific research institutions, industries, and medical institutions in the Yangtze River Delta to help promote "politics, economics, industry, education, research, and medical" in the Yangtze River Delta region. Cooperation, implement relevant policies and standards, optimize industrial service quality, and jointly promote exchanges and cooperation between enterprises in the region.